Huadong Medicine Co., Ltd (SHE:000963)
China flag China · Delayed Price · Currency is CNY
36.28
+0.39 (1.09%)
Feb 3, 2026, 3:04 PM CST

Huadong Medicine Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
62,80260,55372,56582,08770,34246,475
Market Cap Growth
9.41%-16.55%-11.60%16.70%51.35%8.94%
Enterprise Value
61,06858,71170,92381,58369,34146,024
Last Close Price
35.8933.8739.3444.0937.6024.72
PE Ratio
17.0417.2425.5632.8530.5616.48
Forward PE
17.2719.8327.5730.3929.3413.64
PS Ratio
1.461.451.792.182.041.38
PB Ratio
2.562.573.364.284.153.06
P/TBV Ratio
3.603.674.505.925.763.98
P/FCF Ratio
31.8729.9631.2469.0629.9223.98
P/OCF Ratio
16.3016.1518.4734.4622.1913.62
PEG Ratio
1.471.271.271.271.271.27
EV/Sales Ratio
1.421.401.752.162.011.37
EV/EBITDA Ratio
11.4411.5316.4321.6020.9113.32
EV/EBIT Ratio
13.6213.5319.7625.8624.7115.22
EV/FCF Ratio
30.9929.0530.5468.6429.5023.74
Debt / Equity Ratio
0.090.130.090.140.120.13
Debt / EBITDA Ratio
0.430.580.440.670.610.58
Debt / FCF Ratio
1.161.500.832.170.891.03
Asset Turnover
1.111.171.261.301.351.48
Inventory Turnover
5.646.186.256.075.965.57
Quick Ratio
1.161.151.281.231.211.19
Current Ratio
1.561.531.711.731.671.70
Return on Equity (ROE)
15.61%15.48%13.97%14.02%14.56%20.75%
Return on Assets (ROA)
7.24%7.60%6.94%6.78%6.85%8.28%
Return on Invested Capital (ROIC)
16.86%17.55%16.10%16.09%16.02%19.22%
Return on Capital Employed (ROCE)
17.70%18.00%15.80%15.00%15.80%19.40%
Earnings Yield
5.89%5.80%3.91%3.04%3.27%6.07%
FCF Yield
3.14%3.34%3.20%1.45%3.34%4.17%
Dividend Yield
2.58%2.75%1.47%0.66%0.77%0.93%
Payout Ratio
46.05%48.47%20.93%23.07%19.99%20.06%
Buyback Yield / Dilution
-0.26%-0.08%-0.10%-0.00%0.00%-0.00%
Total Shareholder Return
2.32%2.66%1.37%0.66%0.78%0.93%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.